Haug ES - Search Results

1

"Natural course" of disease in patients with metastatic castrate-resistant prostate cancer: Survival and prognostic factors without life-prolonging treatment.

Löffeler S, Weedon-Fekjaer H, Wang-Hansen MS, Sebakk K, Hamre H, Haug ES, Fosså SD. Löffeler S, et al. Among authors: haug es. Scand J Urol. 2015 Dec;49(6):440-445. doi: 10.3109/21681805.2015.1059881. Epub 2015 Jul 3. Scand J Urol. 2015. PMID: 26139461

2

[Cryotherapy in prostatic cancer].

Haug ES, Löffeler S, Urnes T. Haug ES, et al. Tidsskr Nor Laegeforen. 2005 Oct 20;125(20):2835; author reply 2835-6. Tidsskr Nor Laegeforen. 2005. PMID: 16244700 Free article. Norwegian. No abstract available.

3

Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study.

Steinsvik EA, Axcrona K, Angelsen A, Beisland C, Dahl A, Eri LM, Haug ES, Svindland A, Fosså S. Steinsvik EA, et al. Among authors: haug es. Scand J Urol. 2013 Apr;47(2):92-100. doi: 10.3109/00365599.2012.707684. Epub 2012 Aug 6. Scand J Urol. 2013. PMID: 22860630

4

Crude mortality and loss of life expectancy of patients diagnosed with urothelial carcinoma of the urinary bladder in Norway.

Andreassen BK, Myklebust TÅ, Haug ES. Andreassen BK, et al. Among authors: haug es. Scand J Urol. 2017 Feb;51(1):38-43. doi: 10.1080/21681805.2016.1271354. Epub 2017 Jan 13. Scand J Urol. 2017. PMID: 28084860

5

Tumour heterogeneity poses a significant challenge to cancer biomarker research.

Cyll K, Ersvær E, Vlatkovic L, Pradhan M, Kildal W, Avranden Kjær M, Kleppe A, Hveem TS, Carlsen B, Gill S, Löffeler S, Haug ES, Wæhre H, Sooriakumaran P, Danielsen HE. Cyll K, et al. Among authors: haug es. Br J Cancer. 2017 Jul 25;117(3):367-375. doi: 10.1038/bjc.2017.171. Epub 2017 Jun 15. Br J Cancer. 2017. PMID: 28618431 Free PMC article.

6

High Norwegian prostate cancer mortality: evidence of over-reporting.

Löffeler S, Halland A, Weedon-Fekjær H, Nikitenko A, Ellingsen CL, Haug ES. Löffeler S, et al. Among authors: haug es. Scand J Urol. 2018 Apr;52(2):122-128. doi: 10.1080/21681805.2017.1421260. Epub 2018 Jan 11. Scand J Urol. 2018. PMID: 29325479

7

Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging.

Grönberg H, Eklund M, Picker W, Aly M, Jäderling F, Adolfsson J, Landquist M, Haug ES, Ström P, Carlsson S, Nordström T. Grönberg H, et al. Among authors: haug es. Eur Urol. 2018 Dec;74(6):722-728. doi: 10.1016/j.eururo.2018.06.022. Epub 2018 Jul 9. Eur Urol. 2018. PMID: 30001824

8

TECLA-an innovative technical approach for prostate cancer registries.

Christiansen O, Bratt O, Haug ES, Vaktskjold A, Selnes A, Jordhøy M. Christiansen O, et al. Among authors: haug es. Scand J Urol. 2019 Aug;53(4):229-234. doi: 10.1080/21681805.2019.1634148. Epub 2019 Jul 2. Scand J Urol. 2019. PMID: 31264501

9

Non-metastatic prostate cancer: rationale for conservative treatment and impact on disease-related morbidity and mortality in the elderly.

Löffeler S, Halland A, Fawad H, Beisland C, Haug ES. Löffeler S, et al. Among authors: haug es. Scand J Urol. 2020 Apr;54(2):105-109. doi: 10.1080/21681805.2020.1732463. Epub 2020 Mar 5. Scand J Urol. 2020. PMID: 32133899

10

Work status and work ability after radical prostatectomy or active surveillance for prostate cancer.

Nilsson R, Dahl AA, Bernklev T, Kersten H, Haug ES. Nilsson R, et al. Among authors: haug es. Scand J Urol. 2020 Jun;54(3):194-200. doi: 10.1080/21681805.2020.1750473. Epub 2020 Apr 14. Scand J Urol. 2020. PMID: 32285740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page